Domov › Rak jajčnikov › Georgia › Atlanta
Klinične študije za Rak jajčnikov v Atlanta, GA
29 študij za Rak jajčnikov išče udeležence na lokacijah v Atlanta in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Vključevanje udeležencevFaza 2/3
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Winship Cancer Institute of Emory University, Atlanta
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Vključevanje udeležencevFaza 1
- Emory University, Atlanta
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Emory Winship Cancer Institute, Atlanta
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Vključevanje udeležencevOpazovalna študija
- Piedmont Healthcare, Atlanta
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Vključevanje udeležencevFaza 2
- Site 0108 - Emory University Hospital, Atlanta
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Vključevanje udeležencevFaza 3
- Winship Cancer Institute, Emory University, Atlanta
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Vključevanje udeležencevFaza 3
- Winship Cancer Institute of Emory University ( Site 0037), Atlanta
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Vključevanje udeležencevFaza 3
- Winship Cancer Institute At Emory University, Atlanta
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Vključevanje udeležencevFaza 1/2
- Emory University, Atlanta
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Emory University, Atlanta
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Vključevanje udeležencevFaza 3
- Winship Cancer Institute of Emory University ( Site 0086), Atlanta
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
Vključevanje udeležencevFaza 2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Vključevanje udeležencevFaza 1
- Emory University - Winship Cancer Institute, Atlanta
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Vključevanje udeležencevFaza 3
- Emory University, Atlanta
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Winship Cancer Institute, Emory University, Atlanta
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Vključevanje udeležencevFaza 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Vključevanje udeležencev
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- in še 3
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Vključevanje udeležencevFaza 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- in še 3
Clinical Pre-screening Protocol for Ovarian Cancer
Vključevanje udeležencevOpazovalna študija
- Emory Winship Cancer Institute, Atlanta
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Winship Cancer Institute, Emory University, Atlanta
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Vključevanje udeležencevFaza 1/2
- Winship Cancer Institute, Emory University, Atlanta
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Vključevanje udeležencevFaza 2
- GSK Investigational Site, Atlanta
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Emory University Hospital/Winship Cancer Institute, Atlanta
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- USA10-0, Atlanta
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Vključevanje udeležencevFaza 1/2
- Emory Winship Cancer Institute, Atlanta
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Vključevanje udeležencevFaza 2
- Winship Cancer Institute, Emory University, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
Vključevanje udeležencevFaza 1/2
- Emory - Winship Cancer Institute, Atlanta
Študije za Rak jajčnikov v drugih mestih
- Houston, TX89 študij
- New York City, NY69 študij
- Boston, MA61 študij
- Los Angeles, CA50 študij
- Nashville, TN49 študij
- Arlington, VA46 študij
- Philadelphia, PA44 študij
- Columbus, OH39 študij
- St. Louis, MO38 študij
- Chicago, IL36 študij
- San Antonio, TX31 študij
- Cleveland, OH30 študij
Druge študije v Atlanta
- Rak (vse vrste)49 študij
- Nemalicelični pljučni rak47 študij
- Množni mielom42 študij
- Rak dojke41 študij
- Rak prostate33 študij
- Akutna mieločna levkemija31 študij
- Kolorektalni rak29 študij
- Rak pljuč29 študij
- Metastatski rak28 študij
- Velika depresivna motnja25 študij
- Srčno popuščanje25 študij
- Ploščatocelični karcinom glave in vratu24 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.